Li Xue, Guan Cuiping, He Yulong, Wang Yujiong, Liu Xiaoming, Zhou Xuezhang
Key Laboratory of the Ministry of Education for the Conservation and Utilization of Special Biological Resources of Western China, Yinchuan, Ningxia 750021, China; College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, China.
Key Laboratory of the Ministry of Education for the Conservation and Utilization of Special Biological Resources of Western China, Yinchuan, Ningxia 750021, China; College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, China; Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China.
Biomed Res Int. 2016;2016:4020715. doi: 10.1155/2016/4020715. Epub 2016 Jun 19.
Staphylococcus epidermidis (S. epidermidis) is an opportunistic pathogen with low pathogenicity and a cause of the repeated outbreak of bovine mastitis in veterinary clinical settings. In this report, a biofilm model of S. epidermidis was generated and the minimal inhibitory concentration (MIC) and sub-MIC (SMIC) on bacterial cultures were assessed for the following agents: total alkaloids of Sophora alopecuroides (TASA), ciprofloxacin (CIP), and erythromycin (ERY). The formation and characteristic parameters of biofilm were analyzed in terms of XTT assay, silver staining, and confocal laser scanning microscope (CLSM). Results showed that a sub-MIC of TASA could inhibit 50% biofilm of bacterial activity, while 250-fold MIC of CIP and ERY MICs only inhibited 50% and 47% of biofilm formation, respectively. All three agents could inhibit the biofilm formation at an early stage, but TASA showed a better inhibitory effect on the late stage of biofilm thickening. A morphological analysis using CLSM further confirmed the destruction of biofilm by these agents. These results thus suggest that TASA has an inhibitory effect on biofilm formation of clinic S. epidermidis, which may be a potential agent warranted for further study on the treatment prevention of infection related to S. epidermidis in veterinary clinic.
表皮葡萄球菌是一种致病性较低的机会致病菌,也是兽医临床环境中牛乳腺炎反复爆发的病因。在本报告中,构建了表皮葡萄球菌生物膜模型,并评估了苦豆子总生物碱(TASA)、环丙沙星(CIP)和红霉素(ERY)对细菌培养物的最低抑菌浓度(MIC)和亚抑菌浓度(SMIC)。通过XTT法、银染和共聚焦激光扫描显微镜(CLSM)分析生物膜的形成和特征参数。结果表明,TASA的亚抑菌浓度可抑制50%的细菌生物膜活性,而CIP的250倍MIC和ERY的MIC仅分别抑制50%和47%的生物膜形成。所有三种药物均可在生物膜形成早期抑制其形成,但TASA对生物膜增厚后期显示出更好的抑制作用。使用CLSM进行的形态学分析进一步证实了这些药物对生物膜的破坏作用。因此,这些结果表明TASA对临床表皮葡萄球菌生物膜形成具有抑制作用,这可能是一种有潜力的药物,值得进一步研究用于兽医临床中预防和治疗与表皮葡萄球菌相关的感染。